Loading...
The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle
The combined loss of muscle strength and constant fatigue are disabling symptoms for cancer patients undergoing chemotherapy. Doxorubicin, a standard chemotherapy drug used in the clinic, causes skeletal muscle dysfunction and premature fatigue along with an increase in reactive oxygen species (ROS)...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3859698/ https://ncbi.nlm.nih.gov/pubmed/24017970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.freeradbiomed.2013.08.191 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|